Back to search

Article

A robust mRNA signature obtained via Recursive Ensemble Feature Selection predicts the responsiveness of omalizumab in moderate-to-severe asthma

2022-10-24

Abstract excerpt

<h4>Background: </h4> : Not being well controlled by therapy with inhaled corticosteroids and long-acting β2 agonist bronchodilators is a major concern for severe-asthma patients. Current treatment option for these patients is the use of biologicals such as anti-IgE treatment, omalizumab, as add-on therapy. Despite the accepted use of omalizumab, patients do not always benefit from it. Therefore, there is a need t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bfd67346-92d5-51df-aab3-0553e5a2ba37
DOI
10.22541/au.166663264.45554320/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A robust mRNA signature obtained via Recursive Ensemble Feature Selection predicts the responsiveness of omalizumab in moderate-to-severe asthmaDOI 10.22541/au.166663264.45554320/v1
Select a neighboring publication to make it the new centre.